Eris Lifesciences Ltd (BOM:540596)
₹ 1353.8 11.3 (0.84%) Market Cap: 184.29 Bil Enterprise Value: 213.23 Bil PE Ratio: 52.93 PB Ratio: 6.65 GF Score: 93/100

Q3 2021 Eris Lifesciences Ltd Earnings Call Transcript

Jan 28, 2021 / 11:00AM GMT
Release Date Price: ₹623.15 (+2.04%)
Operator

Ladies and gentlemen, good day, and welcome to Eris Lifesciences Q3 FY 2021 Results Conference Call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. V Krishnakumar, Chief Operating Officer and Executive Director of the company. Thank you, and over to you, sir.

V Krishnakumar

Good afternoon, everyone. Am I audible?

Operator

Yes, sir. You are clear and audible.

V Krishnakumar

Great. I'm Krishnakumar, and a hearty welcome to our Q3 conference call. I'm happy to share this quarter's highlights with you.

To begin with, I'm happy to report that the domestic pharmaceutical industry, which we refer to as the IPM, it has returned to more normalcy in terms of operations, and the market has registered a growth of 6.4% in Q3. This is in comparison to 1.1% growth last quarter and a negative 5.2% growth in Q1.

The growth for the month of December has been 8.5%. This growth has been led by chronic and subchronic therapies,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot